Description |
1 online resource (1 PDF file (xx, 147 pages)) : illustrations |
Contents |
Introduction -- The economics of global health and microbial threats -- The economic cost of endemic infectious diseases -- The economics and modeling of emerging infectious diseases and biological risks -- The cost dimensions of antimicrobial resistance -- Investing in national preparedness initiatives against microbial threats -- Accelerating research and development of antimicrobial medical products -- Reimagining sustainable investments to counter microbial threats -- Looking to the future: potential next steps for using economics to manage microbial threats -- Closing remarks |
Summary |
Microbial threats, including endemic and emerging infectious diseases and antimicrobial resistance, can cause not only substantial health consequences but also enormous disruption to economic activity worldwide. While scientific advances have undoubtedly strengthened our ability to respond to and mitigate the mortality of infectious disease threats, events over the past two decades have illustrated our continued vulnerability to economic consequences from these threats. To assess the current understanding of the interaction of infectious disease threats with economic activity and suggest potential new areas of research, the National Academies of Sciences, Engineering, and Medicine planned a 1.5-day public workshop on understanding the economics of microbial threats. This workshop built on prior work of the Forum on Microbial Threats and aimed to help transform current knowledge into immediate action. This publication summarizes the presentations and discussions from the workshop |
Bibliography |
Includes bibliographical references |
Notes |
This activity was supported by contracts between the National Academy of Sciences and the U.S. Agency for International Development; U.S. Army Medical Research and Materiel Command (10003469); U.S. Centers for Disease Control and Prevention (10003518); U.S. Department of Homeland Security (10003591); U.S. Department of Justice: Federal Bureau of Investigation (10003863): National Institute of Allergy and Infectious Diseases/National Institutes of Health (10003776), Uniformed Services University of the Health Sciences (10004290), and U.S. Food and Drug Administration (10002125); and U.S. Department of Veterans Affairs (10003856), and by the American Society for Microbiology, EcoHealth Alliance, Infectious Diseases Society of America, Johnson & Johnson (10003710), Merck & Co., Inc., Sanofi Pasteur, and The University of Hong Kong. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project |
|
Online resource; title from PDF title page (viewed March 12, 2019) |
Subject |
Communicable diseases -- Economic aspects -- Congresses
|
|
Communicable diseases -- Prevention -- Government policy -- Congresses
|
|
Drug resistance in microorganisms -- Economic aspects -- Congresses
|
|
Drug resistance in microorganisms.
|
|
Communicable Diseases -- economics
|
|
Drug Resistance, Microbial
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Drug resistance in microorganisms
|
|
Communicable diseases -- Economic aspects
|
Genre/Form |
proceedings (reports)
|
|
Conference papers and proceedings
|
|
Conference papers and proceedings.
|
|
Actes de congrès.
|
Form |
Electronic book
|
Author |
Trần, T. Anh, rapporteur
|
|
Mundaca Shah, Cecilia, rapporteur
|
|
National Academies of Sciences, Engineering, and Medicine (U.S.). Forum on Microbial Threats, sponsoring body.
|
|
Understanding The Economics of Microbial Threats (Workshop) (2018 : Washington, D.C.)
|
ISBN |
9780309483025 |
|
0309483026 |
|
9780309483032 |
|
0309483034 |
|
9780309483056 |
|
0309483050 |
|